Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Title

Type your Poster Title, then hit apply

Showing 1,267 results.

Thumbnail for Spliceosome-Targeting Therapies in SF3B1-Mutated Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis of Clinical Efficacy and Safety

MDS - 1049

Spliceosome-Targeting Therapies in SF3B1-Mutated Myelodysplastic Syndromes: A Systematic Review and Meta-Analysis of Clinical Efficacy and Safety

Ashil Mulllath

Poster Presenter: Ashil Mulllath

Thumbnail for State-Resolved Regulatory Profiling Identifies Product-Specific Transcription Factor and Pathway Activity in Axi-Cel and Tisa-Cel Infusion Products

CT - 1327

State-Resolved Regulatory Profiling Identifies Product-Specific Transcription Factor and Pathway Activity in Axi-Cel and Tisa-Cel Infusion Products

Trenton Gibson

Poster Presenter: Trenton Gibson

Previous 1...115 116 117 118 119 120 121...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Statin Exposure Is Associated With Improved Survival in Diffuse Large B-Cell Lymphoma: A Large Propensity Score-Matched Real-World Analysis

ABCL - 1468

Statin Exposure Is Associated With Improved Survival in Diffuse Large B-Cell Lymphoma: A Large Propensity Score-Matched Real-World Analysis

Fnu Ashvin Rajeev Pillai

Poster Presenter: Fnu Ashvin Rajeev Pillai

Thumbnail for Stem Cell Support as a Salvage Therapy for Prolonged Severe Hematologic Toxicity Following CAR-T Therapy

CT - 1056

Stem Cell Support as a Salvage Therapy for Prolonged Severe Hematologic Toxicity Following CAR-T Therapy

ZhuoXin Zhang

Poster Presenter: ZhuoXin Zhang

Thumbnail for Stepwise Increase in Mortality With Acute Organ Dysfunction Burden in Lymphoma Hospitalizations: A National Inpatient Sample Analysis (2018-2023)

HL - 607

Stepwise Increase in Mortality With Acute Organ Dysfunction Burden in Lymphoma Hospitalizations: A National Inpatient Sample Analysis (2018-2023)

Ramsha Khan

Poster Presenter: Ramsha Khan

Thumbnail for Steroid-Associated Toxicities and Survival Outcomes in Acute Promyelocytic Leukemia Treated With ATO/ATRA With or Without Chemotherapy

AML - 327

Steroid-Associated Toxicities and Survival Outcomes in Acute Promyelocytic Leukemia Treated With ATO/ATRA With or Without Chemotherapy

Gautam Pantwalawalkar

Poster Presenter: Gautam Pantwalawalkar

Thumbnail for Stratified Analysis of Demographics, Sepsis, Mortality, and Hospital Burden among Diffuse Large B-Cell Lymphoma Patients Receiving CAR-T Cell Therapy in the United States Based on Prior Stem Cell Transplantation

CT - 1485

Stratified Analysis of Demographics, Sepsis, Mortality, and Hospital Burden among Diffuse Large B-Cell Lymphoma Patients Receiving CAR-T Cell Therapy in the United States Based on Prior Stem Cell Transplantation

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

Thumbnail for Study of JAK2 V617F Allele Burden by Droplet Digital PCR in BCR::ABL1-Negative Myeloproliferative Neoplasms and its Implications on Disease Phenotype

MPN - 1017

Study of JAK2 V617F Allele Burden by Droplet Digital PCR in BCR::ABL1-Negative Myeloproliferative Neoplasms and its Implications on Disease Phenotype

Shano Naseem

Poster Presenter: Shano Naseem

$Thumbnail for Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin (Mosun-Pola) Shows a Sustained Progression-Free Survival Benefit Compared With Rituximab Plus Polatuzumab Vedotin (R-Pola) in Patients With Relapsed or Refractory Large B-Cell Lymphoma After Long-Term Follow-Up$

ABCL - 568

Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin (Mosun-Pola) Shows a Sustained Progression-Free Survival Benefit Compared With Rituximab Plus Polatuzumab Vedotin (R-Pola) in Patients With Relapsed or Refractory Large B-Cell Lymphoma After Long-Term Follow-Up

L Elizabeth Budde

Poster Presenter: L Elizabeth Budde

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors